Mesa Laboratories MLAB Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.5×— | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.2× | 1.9×-0.1× | 2×+1.4× | 0.7×0.0× | 0.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.1× | 0.4×0.0× | 0.4×-0.6× | 1×-0.1× | 1×0.0× | |
| Valuation | ||||||
| Market capitalization | $542.27M+3.7% | $433.5M+17.6% | $368.65M-31.5% | $537.85M-16.6% | $644.75M-10.0% | |
| Price / sales | 2.2×0.0× | 1.8×+0.2× | 1.5×-0.7× | 2.2×-0.5× | 2.7×-0.3× | |
| Price / book | 2.9×-0.4× | 2.3×+0.3× | 2.1×-1.1× | 3.1×-0.9× | 4×-0.6× | |
| Dividend yield | 0.6%0.0pp | 0.8%-0.1pp | 0.9%+0.3pp | 0.6%+0.1pp | 0.5%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Mesa Laboratories's profit margins?
- Mesa Laboratories (MLAB) runs a 56.8% gross margin and a 2.3% operating margin, with a 1.5% net margin.
- Where do Mesa Laboratories's ratios come from?
- Every ratio is computed from Mesa Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
